Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot BioSpaceAfter being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioSpace After being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: AstraZeneca, GSK intensify China ties with Sino Biopharm dealsNext: Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK Related Stories Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026 Manufacturing GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy pharminent July 29, 2026 Manufacturing GSK to quit Stevenage for new R&D site in Cambridge pharminent July 28, 2026
